20
Sanofi Chimie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Acebutolol hydrochloride, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 1998-136 - Rev 03
This Chemical Type CEP, issued on July 08, 2016, remains in force until November 24, 2022, ensuring its reliability within the pharmaceutical industry.
Substance Number 871 associated with this CEP further emphasizes